Mechanisms of sympathetic activation in heart failure (Q36690392)

15 August 2017

1 reference

title

Mechanisms of sympathetic activation in heart failure (English)

1 reference

15 August 2017

0 references

Watson AM

1

1 reference

PubMed ID

17184514

15 August 2017

Hood SG

series ordinal

2

1 reference

PubMed ID

17184514

15 August 2017

May CN

series ordinal

3

1 reference

15 August 2017

1 December 2006

1 reference

Clinical and Experimental Pharmacology and Physiology

15 August 2017

1 reference

15 August 2017

33

1 reference

15 August 2017

12

1 reference

15 August 2017

1269-1274

1 reference

Long-Term Trends in the Incidence of and Survival with Heart Failure

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Hormones and hemodynamics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

The Neurohumoral Axis in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Calstabin deficiency, ryanodine receptors, and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Molecular and cellular mechanisms of cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

The adrenergic pathway and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

What is the role of beta-adrenergic signaling in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Volume expansion fails to normally activate neural pathways in the brain of conscious rabbits with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Central AT1 receptors are involved in the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Central mechanisms underlying short- and long-term regulation of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Effect of angiotensin-converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04523.X

10.1111/J.1440-1681.2006.04523.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17184514